Table 4 Percentage of patients experiencing toxicity by treatment arm according to WHO grades

From: Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

 

5FU

5FU-LEV

5FU-FA

5FU-FA-LEV

P -value

P -value

 

n =269

n =310

n =268

n =296

FA effect (n =1143)

LEV effect ( n =1059)

Type of toxicity

G1

G2

G3

G4

G1

G2

G3

G4

G1

G2

G3

G4

G1

G2

G3

G4

all grades

all grades

Vomiting

15

4

0.4

17

7

0.3

0.6

17

8.6

1.9

0.4

22

8.4

1

0.3

0.004

0.11

Diarrhoea

13

5.9

2.2

12

11

3.5

10

19

9

1

12

15

8

1.7

<0.0001

0.56

Mucositis

8.9

3

0.3

0.3

9.7

5.8

0.9

16

8.2

9.7

2.2

17

13

3.7

2.7

<0.0001

0.24

Fever

0.3

0.3

1.5

0.7

0.3

1

1

0.3

0.3

0.0017

0.35

Leukopenia

8.6

6.3

0.7

0.3

9.4

6.8

0.9

9.3

5.2

1.9

0.7

8.8

5.4

0.3

1

0.92

0.77

Anemia

2.6

1.9

1.3

4.5

1.1

3.7

0.7

0.09

0.75

Thrombocytopenia

3.3

0.3

2.6

0.3

0.3

2.2

0.3

0.3

1

0.3

0.20

0.48

Skin

3.3

0.3

3.5

2.3

6.3

3.7

1.1

6.8

4.4

1

<0.0001

0.29

Congiuntivitis

0.6

1.9

1.9

3

0.7

<0.0001

0.77

Alopecia

1.5

0.3

1.3

0.6

3.4

1.1

1.1

2.4

3

0.3

0.0007

0.96

Abdominal pain

1.1

1.3

0.3

0.3

0.3

0.3

2

0.70

0.55

Anorexia

0.3

0.3

0.99

Taste alteration

0.3

0.3

0.99

0.51

Gastric ulcer

0.3

0.3

0.49

0.99

GI tract bleeding

0.3

0.3

0.3

0.87

0.26

Constipation

0.3

1

0.3

0.3

0.7

0.7

0.7

0.96

0.11

Bilirubin

1.1

0.3

0.9

0.3

0.7

0.3

1

0.3

0.96

0.99

Hypertransaminasaemia

2.2

0.3

1.6

0.3

0.3

1.1

1.4

0.3

0.22

0.75

Headhache

0.6

0.25

0.49

Fatigue

0.7

0.6

2.6

1.4

0.3

0.04

0.85

Cardiac

1.1

1.1

0.6

0.3

0.3

0.3

0.7

0.3

0.3

0.57

0.23

Neurotoxicity

0.3

0.3

0.3

0.3

1.1

0.7

0.7

0.10

0.48

Cistitis

0.3

0.3

0.3

0.3

0.7

0.99

0.95

Renal

0.3

0.6

0.3

0.7

0.99

0.97

Vascular

0.3

0.3

0.3

0.3

0.57

0.99

Allergy

0.3

0.7

0.61

0.24

Other

0.6

0.3

0.3

1.4

0.14

0.43

Toxic death

4 (1.5 %)

1 (0.3 %)

5 (1.9 %)

3 (1.0 %)

0.42

0.26